WeVote
Log In

Bill

Bill

SR 105

TARDIVE DYSKINESIA AWARE WEEK

104th Regular Session Introduced by Laura Fine

Illinois designates Tardive Dyskinesia Aware Week to educate the public about a serious medication side effect affecting involuntary movements and neurological function.

Resolution Adopted
0
WeVote Research Nonpartisan
Bill Summary · SR 105

Legislative bill overview

SR 105 designates a specific week in Illinois as "Tardive Dyskinesia Aware Week" to raise public awareness about tardive dyskinesia (TD), a serious neurological condition characterized by involuntary movements that can develop as a side effect of certain psychiatric medications. The resolution was introduced by State Senator Laura Fine and was adopted in May 2025.

Why is this important

Tardive dyskinesia affects thousands of patients taking antipsychotic or anti-nausea medications and can significantly impact quality of life, yet remains poorly understood by the general public and some healthcare providers. Designating an awareness week helps educate patients, caregivers, and medical professionals about early recognition, risk factors, and available treatment options, potentially improving outcomes for affected individuals.

Potential points of contention

  • Limited scope: As a non-binding resolution, this measure raises awareness but doesn't mandate any clinical practice changes, funding for research, or healthcare policy reforms
  • Pharmaceutical context: Some may view the resolution as indirectly benefiting medication manufacturers without addressing systemic issues around informed consent or prescribing practices
  • Resource allocation: Questions may arise about whether symbolic gestures are sufficient compared to direct funding for TD research, treatment access, or patient support programs

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.